These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1361231)

  • 21. Lack of genetic restriction by a potential anti-idiotype vaccine for type B viral hepatitis.
    Kennedy RC; Eichberg JW; Dreesman GR
    Virology; 1986 Jan; 148(2):369-74. PubMed ID: 3484564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodies.
    Burlingham WJ; Jankowska-Gan E; DeVito-Haynes L; Fechner JH; Hogan KT; Claas FH; Mulder A; Wang X; Ferrone S
    J Immunol; 1998 Dec; 161(12):6705-14. PubMed ID: 9862700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further characterization of internal image-bearing anti-idiotypic antibodies: specific binding to immunoglobulin receptors on murine hybridoma cells secreting antibodies to hepatitis B surface antigen.
    Kennedy RC; Henkel RD; Dreesman GR
    Scand J Immunol; 1986 Apr; 23(4):481-9. PubMed ID: 2422739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoaffinity purification of hepatitis B surface antigen using anti-idiotype as a specific eluent.
    Kim WB; Kim BM; Choi EC; Kim BK
    J Immunol Methods; 1990 Jan; 126(1):119-24. PubMed ID: 2303720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of T cell epitopes on hepatitis B surface antigen.
    Vento S
    Ann Ist Super Sanita; 1991; 27(1):37-40. PubMed ID: 1720295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-specific idiotype vaccines. III. Induction of T helper cells by anti-idiotype and tumor cells.
    Raychaudhuri S; Saeki Y; Chen JJ; Kohler H
    J Immunol; 1987 Sep; 139(6):2096-102. PubMed ID: 2442262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). VI. T cell fine specificity.
    Milich DR; Peterson DL; Leroux-Roels GG; Lerner RA; Chisari FV
    J Immunol; 1985 Jun; 134(6):4203-11. PubMed ID: 2580909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel approaches to vaccine development against HBV.
    Thanavala Y
    J Biotechnol; 1996 Jan; 44(1-3):67-73. PubMed ID: 8717388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fine mapping and functional characterization of two immuno-dominant regions from the preS2 sequence of hepatitis B virus.
    Meisel H; Sominskaya I; Pumpens P; Pushko P; Borisova G; Deepen R; Lu X; Spiller GH; Krüger DH; Grens E
    Intervirology; 1994; 37(6):330-9. PubMed ID: 8586531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition ELISA for hepatitis B surface antigen (HBsAg) using monoclonal idiotype-anti-idiotype interaction.
    Kim WB; Jo YW; Choi EC; Kim BK
    J Immunol Methods; 1989 Dec; 125(1-2):273-8. PubMed ID: 2607158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variants.
    Schirmbeck R; Dikopoulos N; Kwissa M; Leithäuser F; Lamberth K; Buus S; Melber K; Reimann J
    Eur J Immunol; 2003 Dec; 33(12):3342-52. PubMed ID: 14635042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.
    Schiött A; Larsson K; Manniche S; Kalliomäki S; Heydenreich AV; Dalsgaard K; Kirkby N
    Int J Pharm; 2011 Jul; 414(1-2):312-20. PubMed ID: 21601626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide-antibody conjugates for tumour therapy: a MHC-class-II-restricted tetanus toxin peptide coupled to an anti-Ig light chain antibody can induce cytotoxic lysis of a human B-cell lymphoma by specific CD4 T cells.
    Yu Z; Healy F; Valmori D; Escobar P; Corradin G; Mach JP
    Int J Cancer; 1994 Jan; 56(2):244-8. PubMed ID: 7906251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody].
    Li W; Cui H; Chang XH; Cheng HY; Cheng YX; Feng J; Fu TY
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human T-helper cell responses to a synthetic peptide derived from the hepatitis B surface antigen.
    Mishra A; Rao KV; Durgapal H; Manivel V; Panda SK
    Immunology; 1993 Jul; 79(3):362-7. PubMed ID: 7691722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides.
    Celis E; Ou D; Otvos L
    J Immunol; 1988 Mar; 140(6):1808-15. PubMed ID: 2450132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mimicry of carcinoembryonic antigen by peptides derived from the structure of an anti-idiotype antibody.
    Chatterjee SK; Tripathi PK; Chakraborty M; Yannelli J; Wang H; Foon KA; Maier CC; Blalock JE; Bhattacharya-Chatterjee M
    Cancer Res; 1998 Mar; 58(6):1217-24. PubMed ID: 9515808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural profile of idiotype, anti-idiotype and anti-anti-idiotype monoclonal antibodies in the HLA-DQ3 antigenic system.
    Iwasaki Y; Takabatake H; Shinji T; Monestier M; Ferrone S
    Eur J Immunol; 1994 Nov; 24(11):2874-81. PubMed ID: 7957578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiotype cascades associated with the CD4-HIV glycoprotein 120 interaction: immunization with anti-idiotypic antibodies induces anti-anti-idiotypic responses with anti-CD4 specificity and in vitro neutralizing activity.
    Shearer MH; Dalgleish AG; Chanh TC; Kennedy RC
    AIDS Res Hum Retroviruses; 2000 Jan; 16(1):77-86. PubMed ID: 10628819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single 10-residue pre-S(1) peptide can prime T cell help for antibody production to multiple epitopes within the pre-S(1), pre-S(2), and S regions of HBsAg.
    Milich DR; McLachlan A; Moriarty A; Thornton GB
    J Immunol; 1987 Jun; 138(12):4457-65. PubMed ID: 2438344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.